Representative office Laboratoires Thea
| Théa is a pioneer and world leader in the creation of preservative-free eye products, including the ABAK® multidose bottle; pioneer and leader of the European market in the field of products for the nutrition of the eyes and for the eyelid’s care; occupies a leading position in Europe among products for the treatment of dry eye, preservative-free treatment of glaucoma, etc. In order to eliminate the trachoma pandemic, at the request of the WHO, the company invented the world’s first antibiotic in eye drops for three-day treatment – Azyter®. 10% of Théa’s total turnover is used for intensive scientific and research activities, the company is the founder of the charity foundation for the prevention of blindness and low vision (Théa Foundation), supports numerous educational and charitable programs. Théa sells its products in more than 75 countries of the world and is currently the leader among all ophthalmic pharmaceutical companies in Europe. After the full-scale invasion of the Russian Federation, the company suspended all commercial and marketing activities that were carried out on the Russian market through its subsidiary Théa Pharma, while at the same time providing medicines of its own production from European countries as humanitarian aid to Ukraine. |
| Alcon is the global leader in eye care, dedicated to helping people see brilliantly. With our 75-plus-year heritage, we are the largest eye care device company in the world – with complementary businesses in Surgical and Vision Care |
| Roche is a global pioneer in pharma and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics, as well as growing capabilities in the area of data analytics help Roche deliver truly personalized healthcare. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neurology. Roche is also the world leader in in vitro diagnostics, tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. The Roche Group, headquartered in Switzerland, is active in over 100 countries and in 2022 employed more than 100,900 people worldwide. In 2022, Roche invested CHF 14 billion in Research and Development. |
| “Bayer” is an international company working in the fields of health care and agriculture. The company’s products and services are aimed at benefiting people and improving their quality of life. “Bayer” adheres to the principles of sustainable development and is a socially and ethically responsible company. “Bayer” in Ukraine is part of the global concern “Bayer AG” (Bayer AG) with headquarters in Leverkusen (Germany). The company has been operating in Ukraine since 1992. About 700 professional employees work to present innovative products and knowledge about them to Ukrainian consumers. “Bayer” in Ukraine is represented in the following areas: pharmaceutical division, non-prescription drugs division and agricultural division. |
| “Polpharma” is the largest Polish manufacturer of medicinal products and active pharmaceutical ingredients. Polpharma products are sold in more than 50 countries of the world. Production is carried out in factories that meet the requirements of Good Manufacturing Practices (GMP). |
| Novartis’ goal is to reinvent medicine to improve and extend people’s lives. Novartis uses innovative science and technology to solve some of the most challenging public health problems. Novartis discovers and develops revolutionary treatments and finds new ways to bring them to as many people as possible. |
| Sona-Pharmexim LLC is a leader in the treatment of dry eye disease* (according to the data of the analytical company Proxima Research by the volume of sales in the retail market in monetary terms according to the results of 2022) |
| For 170 years Bausch + Lomb has been at the forefront of optical innovation. Our unique advancements underscore the quality and craftsmanship of our people around the world. Our mission is to help people see better and live better all over the world – that’s why we started and what we still strive for today. Through unwavering focus rooted in innovation, quality and craftsmanship, we continue to pursue our lifelong vision of protecting and enhancing the gift of sight through every phase of life. |
| Limited Liability Company “Point of View” was established in 2017 as a company that strives to become an assistant for healthcare professionals, providing an opportunity to use modern means of diagnosing and treating ophthalmic diseases in routine medical practice. In 2018, Point of View LLC became the official distributor and authorized representative of Icare Finland Oy. |
| We are the Group of companies which engage in development, production and sale of pharmaceutical products. Presented in more than 35 countries of the world. The main competitive advantage of our company is the support and validation of our research and development from the side of the FDA and the trusting bodies of the European Union, as well as the protection of the rights of the intellectual power of a wide portfolio of our drugs due to the international requirements. |
| UNIMED PHARMA® is European pharmaceutical company which produces ophthalmologic drugs. UNIMED PHARMA® satisfies all standards of quality and holds the necessary certificates to operate and successfully compete on the global pharmaceutical market. UNIMED PHARMA® produces branded generics, many of which have an original composition. A feature of the company’s drug production is the development of formulations that improve patient tolerance. The acquired certificates motivate us toward maintaining high standards we have already achieved, and so we can guarantee the quality and efficacy of the drugs we produce. |
| The first Bank of Tissues in Ukraine. Founder: Andriy Barkanov, General Director (CEO), neurosurgeon. Biomaterials are medical products made from human donor material (cadaver and living donors). The company specializes in the production of: bone material (crumbs, blocks), tendons, dermis, pericardial membrane and broad fascia, costal cartilages, amnion membrane. The products are manufactured according to the standards of the European Association of Tissues Banks. The allograft processing includes careful screening of donors and tissue donation; examination in certified laboratories; standardized tissue cleaning process; sterilization; quality control system; ISO 13485 certification. Our advantages: Official manufacturer of biomaterials – complete package of permit documentation; We produce biomaterials that are already in use (working laboratory); Our specialists constantly improve their qualifications and study at European Tissues Banks. Fields of application: ophthalmology; dentistry; orthopedics; sports medicine; plastic and reconstructive surgery; maxillofacial surgery; neurosurgery; combustiology (burns); wound surgery (diabetic foot, venous lesions). |
| Kyiv Vitamin Plant is a domestic pharmaceutical company-manufacturer, which has occupied a stable position on the national and world market for more than 75 years. The company’s portfolio includes more than 175 drugs. In the production of products, high-quality substances from leading European countries are used. Production meets quality standards. Production lines are GMP certified. The company has its own certified laboratory. The main principle of the company is quality without compromise! |